GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (FRA:3JR) » Definitions » Cash Flow from Operations

Sopharma AD-Sofia (FRA:3JR) Cash Flow from Operations : €23.4 Mil (TTM As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Sopharma AD-Sofia Cash Flow from Operations?

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the three months ended in Dec. 2023, Sopharma AD-Sofia's Cash Receipts from Operating Activities was €307.8 Mil. Its Cash Payments was €-235.6 Mil. Its Dividends Paid was €0.0 Mil. Its Dividends Received was €0.0 Mil. Its Interest Paid was €-1.7 Mil. Its Interest Received was €0.0 Mil. Its Taxes Refund Paid was €-10.6 Mil. And its Cash Flow from Others was €-0.0 Mil. In all, Sopharma AD-Sofia's Cash Flow from Operations for the three months ended in Dec. 2023 was €60.0 Mil.


Sopharma AD-Sofia Cash Flow from Operations Historical Data

The historical data trend for Sopharma AD-Sofia's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma AD-Sofia Cash Flow from Operations Chart

Sopharma AD-Sofia Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only -66.63 -93.07 -39.41 57.11 23.36

Sopharma AD-Sofia Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Flow from Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.09 6.59 -9.39 -33.84 60.00

Sopharma AD-Sofia Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Sopharma AD-Sofia's Cash Flow from Operations for the fiscal year that ended in Dec. 2023 is calculated as:

Sopharma AD-Sofia's Cash Flow from Operations for the quarter that ended in Dec. 2023 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €23.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sopharma AD-Sofia  (FRA:3JR) Cash Flow from Operations Explanation

For non-financial companies reported in direct method, cash flow from operations contains eight items:

1. Cash Receipts from Operating Activities:
Cash Receipts from Operating Activities represents cash received from operating activitiies in direct method.

Sopharma AD-Sofia's cash receipts from operating activities for the three months ended in Dec. 2023 was €307.8 Mil.

2. Cash Payments:
It represents cash flow paid from operating activities in the direct cash flow method.

Sopharma AD-Sofia's cash payments for the three months ended in Dec. 2023 was €-235.6 Mil.

3. Dividends Paid:
It represents dividend paid to the investors in the direct cash flow method.

Sopharma AD-Sofia's cash payments for the three months ended in Dec. 2023 was €0.0 Mil.

4. Dividends Received:
It represents dividend received on the investment in the direct cash flow method.

Sopharma AD-Sofia's cash payments for the three months ended in Dec. 2023 was €0.0 Mil.

5. Interest Paid:
It represents interest paid on loans, debt or borrowings, in the direct cash flow method.

Sopharma AD-Sofia's cash payments for the three months ended in Dec. 2023 was €-1.7 Mil.

6. Interest Received:
It represents interest received by the company in the direct cash flow method.

Sopharma AD-Sofia's cash payments for the three months ended in Dec. 2023 was €0.0 Mil.

7. Taxes Refund Paid:
It represents tax paid or refund related to operating activities in the direct cash flow method.

Sopharma AD-Sofia's cash payments for the three months ended in Dec. 2023 was €-10.6 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of cash receipts and cash payments. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its cash position will grow more slowly (or even shrink).

Sopharma AD-Sofia's cash flow from others for the three months ended in Dec. 2023 was €-0.0 Mil.


Sopharma AD-Sofia Cash Flow from Operations Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's Cash Flow from Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


Sopharma AD-Sofia (FRA:3JR) Business Description

Traded in Other Exchanges
Address
5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are organized based on the production of finished products which include Tablet dosage forms, Ampoule dosage forms, Medical products, Other forms, and Other revenue. Geographically company operates in Bulgaria and internationally.

Sopharma AD-Sofia (FRA:3JR) Headlines

No Headlines